SCHEMBL7529102

SCHEMBL7529102

CCOc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O.[NaH]

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.73
MAPT P10636 4/20 0.73
ALDH1A1 P00352 4/20 0.73
KMT2A Q03164 3/20 0.73
HPGD P15428 4/20 0.52
HSD17B10 Q99714 3/20 0.52
KDM4E B2RXH2 2/20 0.52
RECQL P46063 2/20 0.52
CYP3A4 P08684 1/20 0.52
NR1H4 Q96RI1 1/20 0.43
MAPK1 P28482 2/20 0.43
CYP1A2 P05177 1/20 0.43
PGR P06401 1/20 0.43
CYP2D6 P10635 1/20 0.43
SLC6A2 P23975 1/20 0.43
PDE4A P27815 1/20 0.43
CYP2C19 P33261 1/20 0.43
HRH1 P35367 1/20 0.43
HTT P42858 1/20 0.43
SLC6A3 Q01959 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2988597 0.99 LMNA (0.74) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4661580 0.89 LMNA (0.71) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4660272 0.88 LMNA (0.70) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4660398 0.87 LMNA (0.68) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4662887 0.86 LMNA (0.71) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL7529105 0.86 LMNA (0.57) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4661617 0.86 LMNA (0.67) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4661746 0.86 LMNA (0.67) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4660309 0.86 LMNA (0.67) LMNAMAPTALDH1A1KMT2AHPGD
SCHEMBL4661735 0.86 LMNA (0.67) LMNAMAPTALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020041889-A1 ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION SHISEIDO COMPANY, LTD. (JP) 2002-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020041889-A1 ENHANCING AGENT FOR DEGRADATION OF DESMOSOMES OR STRATUM CORNEUM DESQUAMATION DSG1, DSC1, CUTA LMNA 1600/4885MAPT 2346/4885ALDH1A1 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.